STEMI - ST ELEVATION MYOCARDIAL INFARCTION
Clinical trials for STEMI - ST ELEVATION MYOCARDIAL INFARCTION explained in plain language.
Never miss a new study
Get alerted when new STEMI - ST ELEVATION MYOCARDIAL INFARCTION trials appear
Sign up with your email to follow new studies for STEMI - ST ELEVATION MYOCARDIAL INFARCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart attack patients may benefit from Clot-Busting drug before delayed procedure
Disease control Not yet recruitingThis study looks at 240 adults having a major heart attack (STEMI) when the standard emergency procedure to open the blocked artery is expected to be delayed by over an hour. Half will get a clot-busting drug (tenecteplase) right away, followed by the procedure within 2-24 hours.…
Matched conditions: STEMI - ST ELEVATION MYOCARDIAL INFARCTION
Phase: PHASE4 • Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Wire-Free heart scan could cut unnecessary stents in heart attack patients
Disease control Not yet recruitingThis study tests whether a new wire-free imaging method called μFR can help doctors decide which blocked heart arteries need stents after a heart attack. About 350 patients with multiple blocked arteries will be randomly assigned to standard care or μFR-guided treatment. The goal…
Matched conditions: STEMI - ST ELEVATION MYOCARDIAL INFARCTION
Phase: NA • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Designer cells aim to calm immune system after massive heart attack
Disease control Not yet recruitingThis early-phase trial tests a new treatment for people in shock after a severe heart attack. The therapy uses specially engineered immune cells (CAR-DC) to target a protein found in heart scar tissue, aiming to calm the immune response. The study will enroll 18 patients and prim…
Matched conditions: STEMI - ST ELEVATION MYOCARDIAL INFARCTION
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Heart attack patients get early cholesterol drug in landmark trial
Disease control Not yet recruitingThis study tests whether giving a powerful cholesterol-lowering drug (recaticimab) early after a heart attack can safely reduce future heart problems. About 2,442 adults who recently had a heart attack will receive the drug or standard care. The goal is to see if this approach lo…
Matched conditions: STEMI - ST ELEVATION MYOCARDIAL INFARCTION
Phase: PHASE4 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Heart attack patients to receive injectable gel that may limit damage
Symptom relief Not yet recruitingThis early study tests whether a special gel, injected into the heart during a procedure to open blocked arteries, can safely reduce injury in people having their first major heart attack. Twenty participants will be randomly assigned to get the gel plus standard care or standard…
Matched conditions: STEMI - ST ELEVATION MYOCARDIAL INFARCTION
Phase: NA • Sponsor: Myomed Technology (Shaoxing) Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Could a simple inhaled gas replace morphine for heart attack pain?
Symptom relief Not yet recruitingThis phase 3 trial will compare methoxyflurane (Penthrox®), a painkiller gas patients inhale themselves, against standard morphine injections for chest pain during a heart attack. About 700 adults with a specific type of heart attack (STEMI) will be enrolled in pre-hospital setti…
Matched conditions: STEMI - ST ELEVATION MYOCARDIAL INFARCTION
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Can a chinese herbal tablet help hearts heal after a heart attack?
Knowledge-focused Not yet recruitingThis study looks at whether Guanxinning tablets can help repair tiny blood vessels in the heart after a heart attack. About 70 people who have had a severe heart attack will take the tablets or a placebo for 6 months. The main goal is to see if the tablets reduce bleeding in the …
Matched conditions: STEMI - ST ELEVATION MYOCARDIAL INFARCTION
Phase: PHASE2 • Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Hong kong launches study to track heart shock survival
Knowledge-focused Not yet recruitingThis study will track 320 people in Hong Kong who have a heart attack complicated by cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. Researchers will collect data on standard treatments, including the use of a heart pump called Impella, to…
Matched conditions: STEMI - ST ELEVATION MYOCARDIAL INFARCTION
Sponsor: Prince of Wales Hospital, Shatin, Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC